Showing 1811-1820 of 4118 results for "".
The Importance of Link Building_Part2
https://practicaldermatology.com/topics/practice-management/the-importance-of-link-building-part2/18544/Why is link-building important and how do you do it right? In the second of a 2-part series, Susan Hudson and Jamie Edson discuss ways to build natural and beneficial links. This video is part of a comprehensive suite of Ekwa.com Marketing Educational videos.What is the best thing you've done to improve your practice in the last year?
https://practicaldermatology.com/topics/practice-management/what-is-the-best-thing-you-ve-done-to-improve-your-practice-in-the-last-year/20279/The best thing I did to improve my practice was... PD Asks Ava Shamban, MD how she's improved her practice in the last year. Dr. Shamban says the best thing she did was to develop incentive and goals for her staff. Watch other responses to this question: Joel Gelfand, MDBest Practices: Allan Wirtzer, MD on Leadership
https://practicaldermatology.com/topics/practice-management/best-practices-allan-wirtzer-md-on-leadership/18592/Sometimes the most important role of a physician is leader. Whether in your practice or for your specialty overall, doctors must lead the charge forward. In this edition of Best Practices, host Joel L. Cohen, MD talks to Allan S. Wirtzer, MD about issues affecting medicine, including coding, and theLaser Options for Scars
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-options-for-scars/18814/Advances in laser technology—particularly fractional lasers—offer an effective option for diminishing the appearance of scars, says Jill Waibel, MD. She offers a review of how she's treating all types of scars and skin types, and discusses how and why keloids have been reclassified as a disease.Drug Prices Soar, Amgen Files BLA for Biosimilar to Humira
https://practicaldermatology.com/topics/practice-management/dermwiretv-drug-prices-soar-amgen-files-bla-for-biosimilar-to-humira/18672/In this edition, Amgen Submits ABP 501—first Adalimumab biosimilar; prices for dermatology drugs jump and a survey explores patient knowledge of antibiotic resistance. Also, Almirall acquires Veltin from Sitefel/GSK.Innovation in Dermatology Entrepreneurship
https://practicaldermatology.com/topics/practice-management/innovation-in-dermatology-entrepreneurship/18912/Entrepreneurship in dermatology is "in a good spot," says William Ju, MD, President of Advancing Innovation in Dermatology. Dermatology is a high-growth field, supported by patient demand and globalization and scientific advancements.Thoughts on HIPAA
https://practicaldermatology.com/topics/practice-management/thoughts-on-hipaa/19206/Michael Sacopulos, JD discusses HIPAA compliance for aesthetic practices. (Recorded June 2013)A Guidelines-Based Recommendations Algorithm for Atopic Dermatitis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/a-guidelines-based-recommendations-algorithm-for-atopic-dermatitis/48781/Christopher Bunick, MD, FAAD, compares the four approved and recommended biologics and two approved oral JAK inhibitors for treating atopic dermatitis with oral corticosteroidsPractical Dermatology Roundtable: Generalized Pustular Psoriasis, Ch. 5
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-generalized-pustular-psoriasis-ch-5/32903/Host Neal Bhatia, MD, FAAD, and guests Jason E. Hawkes, MD, MS, FAAD, and Laura K. Ferris, MD, PhD, FAAD, discuss getting clinicians out of the mindset of using traditional IL-17 and IL-23 blockers for generalized pustular psoriasis, understanding that it is a chronic disease that needs a chronic trPhotoprotection in Diverse Patient Populations
https://practicaldermatology.com/programs/practical-dermatology/photoprotection-in-diverse-patient-populations/18196/In part one of a three-part podcast series on dermatologic issues facing patients with darker skin tones, Drs. Andrew Alexis, Corey Hartman, and Janiene Luke discuss photoprotection and why it matters for all patients.